Related references
Note: Only part of the references are listed.5715Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease
P. Noseworthy et al.
EUROPEAN HEART JOURNAL (2017)
Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views
Rugheed Ghadban et al.
Hemodialysis International (2017)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
Giuseppe Ando et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
EVALUATION OF APIXABAN IN PATIENTS ON DIALYSIS
Nhu Quyen Dau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation
Eli N. Deal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
Thomas A. Mavrakanas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
Brooke E. Stanton et al.
PHARMACOTHERAPY (2017)
A Multicenter Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis
Taylor D. Steuber et al.
ANNALS OF PHARMACOTHERAPY (2017)
Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease
Stefanie C. Sarratt et al.
ANNALS OF PHARMACOTHERAPY (2017)
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
Xiaoli Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con
Vaibhav Keskar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
P. A. McCullough et al.
Clinical Journal of the American Society of Nephrology (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling ENGAGE AF-TIMI 48 Analysis
Jan Steffel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan
Cheng-Huang Shen et al.
MEDICINE (2016)
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
Molly W. Mandernach et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation-Quality and Cost Implications
Nihar R. Desai et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD
Ziv Harel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Khai P. Ng et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
Raul Herzog et al.
BMC PUBLIC HEALTH (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2012)
Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation
Wolfgang C. Winkelmayer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Warfarin use in hemodialysis patients: what is the risk?
P. J. Phelan et al.
CLINICAL NEPHROLOGY (2011)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog et al.
KIDNEY INTERNATIONAL (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
Volker Wizemann et al.
KIDNEY INTERNATIONAL (2010)
Unfractionated Heparin for Hemodialysis: Still the Best Option
Robert E. Cronin et al.
SEMINARS IN DIALYSIS (2010)
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Holger Reinecke et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
Kevin E. Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Chronic kidney disease increases risk for venous thromboembolism
Keattiyoat Wattanakit et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
PLOS MEDICINE (2007)
Endothelium-dependent contractions in hypertension
PM Vanhoutte et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
